In contrast, depletion of IL6, IL8, or CCL2 by adding specific neutralizing antibodies to NPC cultures eliminated the cancer growth-promoting effect of Exo-Tx FibroCM, while treatment with isotype IgG control antibodies did not affect this effect (Fig. 3H). The gene discussed is CXCL8; the disease is nasopharyngeal carcinoma.